SBI Securities’s Parabilis Medicines Inc PBLS Stock Holding History

SBI Securities’s Portfolio PBLS Stock Details PBLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$484	Buy	+15	New	+$523	﹤0.01%	3125

Other funds holding PBLS

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SBI Securities's PBLS Position: Q3 2026 in Review

SBI Securities opened a new position in Parabilis Medicines Inc (PBLS) in Q3 2026: 15 shares worth $484. The stake represents ﹤0.01% of the portfolio and ranks #3125 among its holdings.

7 funds tracked by Wall St. Rank hold PBLS as of Q3 2026.

SBI Securities held 15 shares of Parabilis Medicines Inc worth $484 as of Q3 2026.
Parabilis Medicines Inc was a new SBI Securities position in Q3 2026.
Parabilis Medicines Inc made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3125 holding.
7 funds tracked by Wall St. Rank held Parabilis Medicines Inc as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.